Hologic to Webcast Presentations at Upcoming Virtual Investor Conferences
Hologic, Inc. (Nasdaq: HOLX) will present at several upcoming virtual investor conferences, highlighting its commitment to women's health technology. Key events include:
- BTIG Virtual MedTech Conference on February 17 at 10:30 a.m. ET
- Citi’s Healthcare Services Conference on February 24 at 11:40 a.m. ET
- SVB Leerink’s Global Healthcare Conference on February 25 at 1:00 p.m. ET
- Raymond James Institutional Investors Conference on March 1 at 1:20 p.m. ET
All presentations will be webcast live and accessible on Hologic's investor website.
- None.
- None.
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming virtual investor conferences:
- The BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Wednesday, February 17 at 10:30 a.m. Eastern Time (ET).
- Citi’s 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference on Wednesday, February 24 at 11:40 a.m. ET.
- SVB Leerink’s 10th Annual Global Healthcare Conference on Thursday, February 25 at 1:00 p.m. ET.
- The Raymond James Institutional Investors Conference on Monday, March 1 at 1:20 p.m. ET.
Each presentation will be webcast live and may be accessed through a link on the investors section of Hologic’s website at http://investors.hologic.com. The webcasts will be available for 30 days following the events.
About Hologic
Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com
SOURCE: Hologic, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210210005889/en/
FAQ
When is Hologic's presentation at the BTIG Virtual MedTech Conference?
What is the date and time of Hologic's presentation at Citi’s Healthcare Services Conference?
When will Hologic present at the SVB Leerink’s Global Healthcare Conference?
What is the schedule for Hologic at the Raymond James Institutional Investors Conference?